Brookfield Asset Management - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$561,043
-88.9%
13,795
-86.8%
0.00%
-89.5%
Q1 2023$5,053,745
+20.6%
104,330
-4.9%
0.02%
+18.8%
Q4 2022$4,189,501
+21.4%
109,759
+59.7%
0.02%
+23.1%
Q3 2022$3,450,000
+149.1%
68,735
+98.7%
0.01%
+116.7%
Q2 2022$1,385,000
-13.7%
34,585
-19.6%
0.01%0.0%
Q1 2022$1,605,00043,0100.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders